US equities
|
SPCX
$175.06
▲+2.32%
NVDA
$242.32
▲+1.43%
MU
$1,064.33
▲+0.03%
MRVL
$295.57
▲+8.97%
AMD
$641.01
▲+1.47%
SNDK
$1,679.95
▼-1.42%
TSLA
$380.17
▲+0.38%
META
$737.22
▼-0.63%
SPCX
$175.06
▲+2.32%
NVDA
$242.32
▲+1.43%
MU
$1,064.33
▲+0.03%
MRVL
$295.57
▲+8.97%
AMD
$641.01
▲+1.47%
SNDK
$1,679.95
▼-1.42%
TSLA
$380.17
▲+0.38%
META
$737.22
▼-0.63%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
CapsoVision, Inc. - Common Stock
(NQ:
CV
)
6.465
-0.125 (-1.90%)
Delayed Quote
Updated: 9:54 AM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CapsoVision, Inc. - Common Stock
CapsoVision Q2 Earnings Call Highlights
↗
August 13, 2026
CapsoVision (NASDAQ:CV) reported second-quarter revenue growth as sales of its CapsoCam Plus capsule endoscopy system increased, while the company advanced its artificial intelligence software rollout...
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
CapsoVision Q2 2026 Earnings Call Transcript
↗
August 13, 2026
CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call...
Via
Benzinga
Topics
Earnings
CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading
↗
May 14, 2026
Via
Chartmill
CapsoVision Q1 Earnings Call Highlights
↗
May 14, 2026
CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal...
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
April 16, 2026
Via
Chartmill
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Monday's pre-market session: top gainers and losers
↗
December 15, 2025
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
Unusual volume stocks in Friday's session
↗
December 12, 2025
Unusual volume stocks are being observed in Friday's session.
Via
Chartmill
CapsoVision Inc (NASDAQ:CV) Misses Q3 2025 Earnings and Revenue Estimates
↗
November 13, 2025
CapsoVision (CV) missed Q3 2025 earnings and revenue estimates. The medical tech firm posted a wider-than-expected loss per share and lower sales.
Via
Chartmill
CapsoVision Revenue Jumps 17 Percent
↗
August 14, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
InvestorNewsBreaks – Roth Capital Partners Serves as Joint Book-Running Manager for CapsoVision (NASDAQ: CV) $27.5 Million IPO
July 24, 2025
Via
Investor Brand Network
Topics
Derivatives
Initial Public Offering
